AO GENERIUM
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 10/7/2024
Pipeline by Phase
Therapeutic Focus
Clinical Trials (23)
Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction
Started: 5/25/2014
An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease
Started: 12/12/2023
An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis
Started: 7/25/2023
Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid Arthritis
Started: 2/13/2023
Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients
Started: 3/28/2022
Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP
Started: 9/9/2021
Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH
Started: 11/29/2017
A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation)
Started: 5/3/2018
An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma
Started: 6/20/2018
Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19
Started: 6/1/2020
Efficacy and Safety of Tigerase® vs. Pulmozyme® in Patients With Cystic Fibrosis
Started: 8/30/2017
A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II
Started: 11/30/2021
Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema
Started: 12/1/2021
A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.
Started: 10/7/2024
A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers
Started: 6/20/2024
A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers
Started: 1/15/2023
A Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers
Started: 4/6/2023
A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers
Started: 3/11/2022
A Safety and Pharmacokinetic Study of Complarate (Tocilizumab Biosimilar) and Actemra® in Healthy Volunteers
Started: 4/11/2022
A Safety, Pharmacokinetics and Pharmacodynamics Study of GNR-086 and Ilaris® in Healthy Volunteers
Started: 9/6/2022
Study of Pharmacokinetics, Pharmacodynamics and Safety Assessment of GNR-044 (JSC GENERIUM, Russia) and Xolair®
Started: 4/18/2017
A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers
Started: 2/28/2020
Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers
Started: 3/10/2020